Low-level amplification of oncogenes correlates inversely with age for patients with nontypical meningiomas.
暂无分享,去创建一个
A. Nanda | M. Nordberg | Kristopher M. Katira | M. Beckner | R. Sampath | Shashikant Patil | Dwain D'Souza | Ashley Flowers | R. B. Patel
[1] Arie Perry,et al. Identification of Gene Markers Associated With Aggressive Meningioma by Filtering Across Multiple Sets of Gene Expression Arrays , 2011, Journal of neuropathology and experimental neurology.
[2] Sally Freels,et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. , 2010, Neuro-oncology.
[3] T. Hyslop,et al. Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma , 2010, Radiation oncology.
[4] M. Ferrer,et al. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. , 2010, Histology and histopathology.
[5] D. Louis,et al. Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome , 2009, Journal of neuropathology and experimental neurology.
[6] K. Mori,et al. The Sterol-sensing Endoplasmic Reticulum (ER) Membrane Protein TRC8 Hampers ER to Golgi Transport of Sterol Regulatory Element-binding Protein-2 (SREBP-2)/SREBP Cleavage-activated Protein and Reduces SREBP-2 Cleavage* , 2009, The Journal of Biological Chemistry.
[7] Michael R. Green,et al. F-Box Protein FBXO31 Mediates Cyclin D1 Degradation to Induce G1 Arrest Following DNA Damage , 2009, Nature.
[8] E. Eichler,et al. Human copy number polymorphic genes , 2009, Cytogenetic and Genome Research.
[9] C. Beetz,et al. Methylation-specific multiplex ligation-dependent probe amplification in meningiomas , 2008, Journal of Neuro-Oncology.
[10] Philippe Froguel,et al. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. , 2007, Human molecular genetics.
[11] R. Mirimanoff,et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. , 2007, International journal of radiation oncology, biology, physics.
[12] Alberto Orfao,et al. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. , 2007, Neuro-oncology.
[13] J. Rey,et al. Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma. , 2007, Cancer genetics and cytogenetics.
[14] A. Órfão,et al. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. , 2003, Journal of Clinical Oncology.
[15] S. Artan,et al. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. , 2002, Acta neurologica Belgica.
[16] M. Schmid,et al. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF , 2000, Oncogene.
[17] K. Hoang-Xuan,et al. Frequent Loss of 1p32 Region but no Mutation if the p18 Tumor Suppressor Gene in Meningiomas , 2000, Journal of Neuro-Oncology.
[18] J. Rey,et al. High-resolution analysis of chromosome arm 1p alterations in meningioma. , 2000, Cancer genetics and cytogenetics.
[19] J. Bischoff,et al. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. , 1999, Trends in cell biology.
[20] B. Scheithauer,et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. , 1998, Mayo Clinic proceedings.
[21] M. Wolter,et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Black,et al. Expression and activation of epidermal growth factor receptors in meningiomas. , 1997, Journal of neurosurgery.
[23] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.
[24] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[25] M. Berger,et al. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.
[26] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[27] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .